Loss of HOXC6 expression induces apoptosis in prostate cancer cells

Oncogene

Volumn 24, Issue 1, 2005, Pages 188-198

  Ramachandran, Sumathi ^a   Liu, Pengbo ^a   Young, Andrew N ^a,b   Yin Goen, Qiqin ^a,b   Lim, So Dug ^a   Laycock, Noelani ^a   Amin, Mahul B ^a   Carney, Jeffrey K ^a   Marshall, Fray F ^a   Petros, John A ^a,b   Moreno, Carlos S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Apoptosis; HOXC6; IGFBP 3; Microarray; NEP; Prostate cancer; siRNA

Indexed keywords

ANDROGEN; GREEN FLUORESCENT PROTEIN; HOMEODOMAIN PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOMEOBOX C6; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE REPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; UPREGULATION; VALIDATION PROCESS;

APOPTOSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; NEPRILYSIN; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING;

MAMMALIA; VECTORS;

EID: 19944432122     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207906     Document Type: Article

References (53)

1. Abate-Shen C. (2002). Nat. Rev. Cancer, 2, 777-785.
2. Abdulkadir SA, Magee JA, Peters TJ, Kaleem Z, Naughton CK, Humphrey PA and Milbrandt J. (2002). Mol. Cell. Biol., 22, 1495-1503.
3. Aberdam D, Negreanu V, Sachs L and Blatt C. (1991). Mol. Cell. Biol., 11, 554-557.
4. ACS (2003). American Cancer Society.
5. Bodey B, Bodey Jr B, Groger AM, Siegel SE and Kaiser HE. (2000a). Anticancer Res., 20, 2711-2716.
6. Bodey B, Bodey Jr B, Siegel SE and Kaiser HE. (2000b). Anticancer Res., 20, 1769-1780.
7. Bodey B, Bodey Jr B, Siegel SE and Kaiser HE. (2000c). Anticancer Res., 20, 3281-3286.
8. Bodey B, Bodey Jr B, Siegel SE, Luck JV and Kaiser HE. (2000d). Anticancer Res., 20, 2717-2721.
9. Bolstad BM, Irizarry RA, Astrand M and Speed TP. (2003). Bioinformatics, 19, 185-193.
10. Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi OP and Gelmann EP. (2000). Cancer Res., 60, 6111-6115.
11. Braasch DA and Corey DR. (2002). Biochemistry, 41, 4503-4510.
12. Castronovo V, Kusaka M, Chariot A, Gielen J and Sobel M. (1994). Biochem. Pharmacol., 47, 137-143.
13. Chariot A, Castronovo V, Le P, Gillet C, Sobel ME and Gielen J. (1996). Biochem. J., 319 (Part 1), 91-97.
14. Chen H, Nandi AK, Li X and Bieberich CJ. (2002). Cancer Res., 62, 338-340.
15. Cheng WS, Giandomenico V, Pastan I and Essand M. (2003). Endocrinology, 144, 3433-3440.
16. Cillo C. (1994). Invasion Metast., 14, 38-49.
17. DeYoung MP, Tress M and Narayanan R. (2003). Proc. Natl. Acad. Sci. USA, 100, 4760-4765.
18. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA and Chinnaiyan AM. (2001). Nature, 412, 822-826.
19. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. (2001). Nature, 411, 494-498.
20. Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, Klaren R, Grone EF, Wiesel M, Gudemann C, Kuster J, Schott W, Staehler G, Kretzler M, Hollstein M and Grone HJ. (2002). Am. J. Pathol., 160, 2169-2180.
21. Essand M, Vasmatzis G, Brinkmann U, Duray P, Lee B and Pastan I. (1999). Proc. Natl. Acad. Sci. USA, 96, 9287-9292.
22. Fanayan S, Firth SM, Butt AJ and Baxter RC. (2000). J. Biol. Chem., 275, 39146-39151.
23. Felsher DW. (2003). Nat. Rev. Cancer, 3, 375-380.
24. Firth SM and Baxter RC. (2002). Endocrinol. Rev., 23, 824-854.
25. Garcia-Gasca A and Spyropoulos DD. (2000). Dev. Dyn., 219, 261-276.
26. Grimberg A, Liu B, Bannerman P, El-Deiry WS and Cohen P. (2002). Int. J. Oncol., 21, 327-335.
27. Hu G, Lee H, Price SM, Shen MM and Abate-Shen C. (2001). Development, 128, 2373-2384.
28. Jones FS, Holst BD, Minowa O, De Robertis EM and Edelman GM. (1993). Proc. Natl. Acad. Sci. USA, 90, 6557-6561.
29. Kawabe T, Muslin AJ and Korsmeyer SJ. (1997). Nature, 385, 454-458.
30. Kirn MJ, Bhatia-Gaur R, Banach-Petrosky WA, Desai N, Wang Y, Hayward SW, Cunha GR, Cardiff RD, Shen MM and Abate-Shen C. (2002a). Cancer Res., 62, 2999-3004.
31. Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM and Abate-Shen C. (2002b). Proc. Natl. Acad. Sci. USA, 99, 2884-2889.
32. Krishnan AV, Peehl DM and Feldman D. (2003). J. Cell. Biochem., 88, 363-371.
33. Lewis EB. (1978). Nature, 276, 565-570.
34. Loy CJ, Sim KS and Yong EL. (2003). Proc. Natl. Acad. Sci. USA, 100, 4562-4567.
35. Luo L, Yang X, Takihara Y, Knoetgen H and Kessel M. (2004). Nature, 427, 749-753.
36. Magee JA, Abdulkadir SA and Milbrandt J. (2003). Cancer Cell, 3, 273-283.
37. Maulbecker CC and Gruss P. (1993). Cell Growth Differ., 4, 431-441.
38. Miller GJ, Miller HL, van Bokhoven A, Lambert JR, Werahera PN, Schirripa O, Lucia MS and Nordeen SK. (2003). Cancer Res., 63, 5879-5888.
39. Moreno CS, Park S, Nelson K, Ashby D, Hubalek F, Lane WS and Pallas DC. (2000). J. Biol. Chem., 275, 5257-5263.
40. Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen IM, Feinberg AP, Jenkins NA, Copeland NG and Shaughnessy Jr JD. (1996). Nat. Genet., 12, 154-158.
41. Rajah R, Valentinis B and Cohen P. (1997). J. Biol. Chem., 272, 12181-12188.
42. Shen R, Sumitomo M, Dai J, Hardy DO, Navarro D, Usmani B, Papandreou CN, Hersh LB, Shipp MA, Freedman LP and Nanus DM. (2000). Mol. Cell Endocrinol., 170, 131-142.
43. Stein S, Fritsch R, Lemaire L and Kessel M. (1996). Mech. Dev., 55, 91-108.
44. Sumitomo M, Milowsky MI, Shen R, Navarro D, Dai J, Asano T, Hayakawa M and Nanus DM. (2001). Cancer Res., 61, 3294-3298.
45. Sumitomo M, Shen R, Goldberg JS, Dai J, Navarro D and Nanus DM. (2000). Cancer Res., 60, 6590-6596.
46. Thelen P, Burfeind P, Grzmil M, Voigt S, Ringert RH and Hemmerlein B. (2004). Int. J. Oncol., 24, 1085-1092.
47. Tusher VG, Tibshirani R and Chu G. (2001). Proc. Natl. Acad. Sci. USA, 98, 5116-5121.
48. Velasco-Miguel S, Buckbinder L, Jean P, Gelbert L, Talbott R, Laidlaw J, Seizinger B and Kley N. (1999). Oncogene, 18, 127-137.
49. Wei H and Pallas DC. (2003) unpublished data.
50. Wolfgang CD, Essand M, Lee B and Pastan I. (2001). Cancer Res., 61, 8122-8126.
51. Wolfgang CD, Essand M, Vincent JJ, Lee B and Pastan I. (2000). Proc. Natl. Acad. Sci. USA, 97, 9437-9442.
52. Xia X, Cheng A, Akinmade D and Hamburger AW. (2003). Mol. Cell. Biol., 23, 1717-1725.
53. Yoshinouchi M, Yamada T, Kizaki M, Fen J, Koseki T, Ikeda Y, Nishihara T and Yamato K. (2003). Mol. Ther., 8, 762-768.